Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
Brzheskiy VV, Efimova EL, Vorontsova TN, Alekseev VN, Gusarevich OG, Shaidurova KN, Ryabtseva AA, Andryukhina OM, Kamenskikh TG, Sumarokova ES, Miljudin ES, Egorov EA, Lebedev OI, Surov AV, Korol AR, Nasinnyk IO, Bezditko PA, Muzhychuk OP, Vygodin VA, Yani EV, Savchenko AY, Karger EM, Fedorkin ON, Mironov AN, Ostapenko V, Popeko NA, Skulachev VP, Skulachev MV.
Brzheskiy VV, et al.
Adv Ther. 2015 Dec;32(12):1263-79. doi: 10.1007/s12325-015-0273-6. Epub 2015 Dec 11.
Adv Ther. 2015.
PMID: 26660938
Free PMC article.
Clinical Trial.
INTRODUCTION: This article presents the results of an international, multicenter, randomized, double-masked, placebo-controlled clinical study of Visomitin (Mitotech LLC, Moscow, Russian Federation) eye drops in patients with dry eye syndrome (DES). ...CONCLUSION: Based on …
INTRODUCTION: This article presents the results of an international, multicenter, randomized, double-masked, placebo-controlled clinical stu …